Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-14793.9South Korea
LB.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.7.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.7.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.7.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.7.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDAEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDAECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDAECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDAEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDAEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JG.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JG.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used